Literature DB >> 26734872

Clinical exuberance of classic Kaposi's sarcoma and response to radiotherapy.

Jeniffer Muñoz Trujillo1, Natália Ribeiro de Magalhães Alves1, Paula Mota Medeiros1, Luna Azulay-Abulafia1, Maria de Fátima Guimarães Scotelaro Alves1, Alexandre Carlos Gripp1.   

Abstract

Kaposi's sarcoma (KS) is a multicentric vascular neoplasm, with cutaneous and extracutaneous involvement. Different clinical and epidemiological variants have been identified. The classic form is manifested mainly in elderly men with indolent and long-term evolution, with lesions localized primarily in the lower extremities. We present two cases of classic Kaposi's sarcoma (CKS) in two female patients with extensive, exuberant skin involvement and rapid evolution, with good response to radiotherapy.

Entities:  

Mesh：

Year:  2015        PMID： 26734872      PMCID： PMC4689079          DOI： 10.1590/abd1806-4841.20153877

Source DB:  PubMed          Journal:  An Bras Dermatol        ISSN： 0365-0596            Impact factor:   1.896


  10 in total

1.  Staging of classic Kaposi's sarcoma: a useful tool for therapeutic choices.

Authors:  Lucia Brambilla; Vinicio Boneschi; Michela Taglioni; Silvia Ferrucci
Journal:  Eur J Dermatol       Date:  2003 Jan-Feb       Impact factor: 3.328

Review 2.  Kaposi sarcoma: review and medical management update.

Authors:  Mahnaz Fatahzadeh
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol       Date:  2011-09-01

Review 3.  Epidemiology and clinical characteristics of classic Kaposi's sarcoma, seroprevalence, and variants of human herpesvirus 8 in South America: a critical review of an old disease.

Authors:  Salim Mohanna; Vicente Maco; Francisco Bravo; Eduardo Gotuzzo
Journal:  Int J Infect Dis       Date:  2005-09       Impact factor: 3.623

4.  Variable clinical presentations of Classic Kaposi Sarcoma in Turkish patients.

Authors:  Ilknur Altunay; Asli Kucukunal; Gulsen Tukenmez Demirci; Bilge Ates
Journal:  J Dermatol Case Rep       Date:  2012-03-27

Review 5.  Systemic treatment of AIDS-related Kaposi sarcoma: current status and perspectives.

Authors:  Tazio Vanni; Eduardo Sprinz; Marcelo Warlet Machado; Rodrigo de C Santana; Benedito Antonio L Fonseca; Gilberto Schwartsmann
Journal:  Cancer Treat Rev       Date:  2006-07-24       Impact factor: 12.111

Review 6.  Treatments for classic Kaposi sarcoma: a systematic review of the literature.

Authors:  Elodie Régnier-Rosencher; Bernard Guillot; Nicolas Dupin
Journal:  J Am Acad Dermatol       Date:  2012-06-12       Impact factor: 11.527

7.  Classic Kaposi's sarcoma presenting in the oral cavity of two HIV-negative Quechua patients.

Authors:  Salim Mohanna; Francisco Bravo; Juan Carlos Ferrufino; Juvenal Sanchez; Eduardo Gotuzzo
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2007-09-01

8.  Gastroscopic findings in Mediterranean Kaposi's sarcoma (non-AIDS).

Authors:  G Kolios; A Kaloterakis; A Filiotou; A Nakos; S Hadziyannis
Journal:  Gastrointest Endosc       Date:  1995-10       Impact factor: 9.427

Review 9.  Kaposi sarcoma.

Authors:  Oana Radu; Liron Pantanowitz
Journal:  Arch Pathol Lab Med       Date:  2013-02       Impact factor: 5.534

10.  Non-AIDS associated Kaposi's sarcoma: clinical features and treatment outcome.

Authors:  Lena Jakob; Gisela Metzler; Ko-Ming Chen; Claus Garbe
Journal:  PLoS One       Date:  2011-04-12       Impact factor: 3.240
  10 in total
  2 in total

1.  Atypical Kaposi's sarcoma in young inmunocompetent patient.

Authors:  Josefa Sánchez-López; Santiago Pérez-Parra; María Librada Porriño-Bustamante; José Aneiros-Fernández; Ramón Naranjo-Sintes; María Antonia Fernández-Pugnaire
Journal:  An Bras Dermatol       Date:  2017       Impact factor: 1.896

2.  Kaposi Sarcoma in an Human Immunodeficiency Virus (HIV)-Seronegative Mediterranean Female: Report of a Rare Case.

Authors:  Marios Grigoriou; Konstantinia E Kofina; Aristeidis Ioannidis; Domniki K Gerasimidou; Christoforos Efthymiadis; Thomas Zaramboukas
Journal:  Am J Case Rep       Date:  2017-07-26
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.